首页> 美国卫生研究院文献>Journal of Pharmaceutics >Development and Evaluation of Dual Cross-Linked Pulsatile Beads for Chronotherapy of Rheumatoid Arthritis
【2h】

Development and Evaluation of Dual Cross-Linked Pulsatile Beads for Chronotherapy of Rheumatoid Arthritis

机译:类风湿关节炎慢性治疗的双交联搏动微珠的研制与评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the present investigation, pulsatile release beads were prepared by ionic gelation technique. Lornoxicam dual cross-linked beads were prepared by dropping dispersed phase of lornoxicam, pectin, and sodium alginate into the dispersion phase of different concentrations of calcium chloride solution followed by aluminium chloride solution. The formulated beads were further coated by Eudragit L & S 100 in the ratio 1 : 2 w/w in order to achieve desired lag time. In vitro release study showed lag time of 5–8 h before release of lornoxicam from the formulated beads. Thus, formulated dual cross-linked beads when administered at bed time may release lornoxicam when needed most for chronotherapeutics of early morning rheumatoid arthritis attacks in chronic patients.
机译:在本研究中,通过离子凝胶技术制备了脉冲释放珠。通过将氯诺昔康,果胶和海藻酸钠的分散相滴入不同浓度的氯化钙溶液然后是氯化铝溶液的分散相中来制备氯诺昔康双交联珠。用Eudragit L&S 100以1∶∶→2 w / w的比例进一步涂覆配制的珠粒,以获得所需的滞后时间。体外释放研究表明,氯诺昔康从配制的珠粒释放之前的滞后时间为5-8–h。因此,配制的双交联磁珠在就寝时间给药时,最需要用于慢性患者清晨类风湿关节炎发作的计时治疗时,释放氯诺昔康。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号